Results for
""Depressive Disorder""[mesh_terms]

Role of copper and ketamine in major depressive disorder - an update.

Jakub Słupski, Anita Słupska, Łukasz P Szałach, Adam Włodarczyk, Natalia Górska, Joanna Szarmach, Katarzyna Jakuszkowiak-Wojten, Maria Gałuszko-Węgielnik, Alina Wilkowska, Mariusz S Wiglusz, Wiesław Jerzy Cubała

Psychiatria Danubina 2019;31(Suppl 3):520-523

Vitamin D and N-Acetyl Cysteine Supplementation in Treatment-Resistant Depressive Disorder Patients: A General Review.

Flavia di Michele, Alessandra Talamo, Cinzia Niolu, Alberto Siracusano

Current pharmaceutical design 2020;26(21):2442-2459

A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials.

Lakshmi N Yatham, Richard C Shelton, Ulrich Hegerl, Luca Sforzini, Courtney Worrell, Melisa Kose, Ian M Anderson, Bruno Aouizerate, Volker Arolt, Michael Bauer, Bernhard T Baune, Pierre Blier, Anthony J Cleare, Philip J Cowen, Timothy G Dinan, Andrea Fagiolini, I Nicol Ferrier, Andrew D Krystal, Marion Leboyer, R Hamish McAllister-Williams, Roger S McIntyre, Andreas Meyer-Lindenberg, Andrew H Miller, Charles B Nemeroff, Claus Normann, David Nutt, Stefano Pallanti, Luca Pani, Brenda W J H Penninx, Alan F Schatzberg, Allan H Young, Roland Zahn, Georgios Aislaitner, Florence Butlen-Ducuing, Christine Fletcher, Marion Haberkamp, Thomas Laughren, Fanni-Laura Mäntylä, Koen Schruers, Andrew Thomson, Gara Arteaga-Henríquez, Francesco Benedetti, Lucinda Cash-Gibson, Woo Ri Chae, Heidi De Smedt, Stefan M Gold, Witte J G Hoogendijk, Valeria Jordán Mondragón, Eduard Maron, Jadwiga Martynowicz, Elisa Melloni, Christian Otte, Gabriela Perez-Fuentes, Sara Poletti, Mark E Schmidt, Edwin van de Ketterij, Katherine Woo, Yanina Flossbach, J Antoni Ramos-Quiroga, Adam J Savitz, Carmine M Pariante

Molecular psychiatry 2022;27(3):1286-1299

Low-carbohydrate diet as a nutritional intervention in a major depression disorder: focus on relapse prevention.

Wiesław Jerzy Cubała, Michał Walaszek, Zofia Kachlik

Nutritional neuroscience 2024;27(10):1185-1198

A double-blind placebo-controlled trial of minocycline on translocator protein distribution volume in treatment-resistant major depressive disorder.

Sophia Attwells, Elaine Setiawan, Pablo M Rusjan, Cynthia Xu, Stephen J Kish, Neil Vasdev, Sylvain Houle, Apitharani Santhirakumar, Jeffrey H Meyer

Translational psychiatry 2021;11(1):334

Oral ketamine for depression: An updated systematic review.

Shakila Meshkat, Sipan Haikazian, Joshua D Di Vincenzo, Farhan Fancy, Danica Johnson, David Chen-Li, Roger S McIntyre, Rodrigo Mansur, Joshua D Rosenblat

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2023;24(7):545-557

Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.

Lee Phan, Sebastian Badulescu, Hartej Gill, Sabrina Wong, Angela T H Kwan, Kayla M Teopiz, Rodrigo B Mansur, Roger Ho, Taeho Greg Rhee, Joshua D Di Vincenzo, Roger S McIntyre, Joshua D Rosenblat, Gia Han Le, Hezekiah Au

Journal of affective disorders 2024;355():342-354

Multimodal predictors of response to intravenous ketamine in treatment-resistant depression: toward personalized treatment in major depressive and bipolar disorders.

Magda Malewska-Kasprzak, Filip Rybakowski, Monika Dmitrzak-Weglarz

CNS spectrums 2026;31(1):e41

Imaging genetics paradigms in depression research: Systematic review and meta-analysis.

Lícia P Pereira, Cristiano A Köhler, Brendon Stubbs, Kamilla W Miskowiak, Gerwyn Morris, Bárbara P de Freitas, Trevor Thompson, Brisa S Fernandes, André R Brunoni, Michael Maes, Diego A Pizzagalli, André F Carvalho

Progress in neuro-psychopharmacology & biological psychiatry 2019;86():102-113

Role of Adiposity-Driven Inflammation in Depressive Morbidity.

Lucile Capuron, Julie Lasselin, Nathalie Castanon

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2018;42(1):115-128

Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol.

Stuart J Eisendrath, Erin P Gillung, Kevin L Delucchi, Maggie Chartier, Daniel H Mathalon, Jude C Sullivan, Zindel V Segal, Mitchell D Feldman

BMC complementary and alternative medicine 2015;14():95

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.

Carola Rong, Caroline Park, Joshua D Rosenblat, Mehala Subramaniapillai, Hannah Zuckerman, Dominika Fus, Yena L Lee, Zihang Pan, Elisa Brietzke, Rodrigo B Mansur, Danielle S Cha, Leanna M W Lui, Roger S McIntyre

International journal of environmental research and public health 2019;15(4):771

Targeting Inflammatory-Mitochondrial Response in Major Depression: Current Evidence and Further Challenges.

Ana Paula Vargas Visentin, Rafael Colombo, Ellen Scotton, Débora Soligo Fracasso, Adriane Ribeiro da Rosa, Catia Santos Branco, Mirian Salvador

Oxidative medicine and cellular longevity 2021;2020():2972968

Comparative Benefits and Harms of Complementary and Alternative Medicine Therapies for Initial Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.

Gary N Asher, Gerald Gartlehner, Bradley N Gaynes, Halle R Amick, Catherine Forneris, Laura C Morgan, Emmanuel Coker-Schwimmer, Erin Boland, Linda J Lux, Susan Gaylord, Carla Bann, Christiane Barbara Pierl, Kathleen N Lohr

Journal of alternative and complementary medicine (New York, N.Y.) 2018;23(12):907-919